Journal of the American Society of Nephrology, Vol 5, 1469-1475, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection

J Wagner, S Volk, CC Haufe, A Ciechanowicz, M Paul and E Ritz
Department of Nephrology, Universities of Heidelberg, Germany.

The expression of renin mRNA was determined by a quantitative polymerase chain reaction assay in 27 human kidney samples: (1) 15 biopsies of patients with glomerulonephritis with or without angiotensin-converting enzyme inhibitor (ACEI) treatment; (2) biopsies of six renal allografts with graft rejection; and (3) six biopsy samples from unaffected parts of tumor nephrectomy specimens as controls. After isolation of RNA, 0.5 to 1 microgram of total RNA was used for reverse transcription to generate cDNA. The human renin gene was subsequently amplified by the use of two primers spanning the second and third exons. Renin expression was quantified with a renin cDNA mutant as the internal standard. It exhibited the same primer binding sites as the endogenous gene but carried a 155-basepair deletion, thus yielding a shorter amplification product. The number of glomeruli was counted by microscopic transillumination immediately after biopsy (median, 9 per biopsy; range, 2 to 23). Renin mRNA was expressed as femtograms of renin mRNA per glomerulus. Renin gene expression was lower in glomerulonephritic patients without ACEI treatment compared with that in control tumor nephrectomy samples, i.e., 63 +/- 20 (N = 7) versus 250 +/- 50 fg (N = 6) of renin mRNA/glomerulus, (P < 0.02), although plasma renin concentration in the glomerulonephritic patients was in the normal range. Significantly higher renin mRNA expression was found in glomerulonephritic patients treated with ACEI, i.e., 210 +/- 50 (N = 8) compared with 63 +/- 20 (N = 7) fg of renin mRNA/glomerulus in patient not treated with ACEI (P < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				H. Schmid, C. D. Cohen, A. Henger, D. Schlondorff, and M. Kretzler Gene expression analysis in renal biopsies Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1347 - 1351. [Full Text] [PDF]

				L. J. Striker and G. E. Striker Windows on Renal Biopsy Interpretation: Does mRNA Analysis Represent a New Gold Standard? J. Am. Soc. Nephrol., April 1, 2003; 14(4): 1096 - 1098. [Full Text] [PDF]

				M. Kretzler, C. D. Cohen, P. Doran, A. Henger, S. Madden, E. F. Grone, P. J. Nelson, D. Schlondorff, and H.-J. Grone Repuncturing the Renal Biopsy: Strategies for Molecular Diagnosis in Nephrology J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1961 - 1972. [Abstract] [Full Text] [PDF]

				C. Dechow, C. Morath, J. Peters, I. Lehrke, R. Waldherr, V. Haxsen, E. Ritz, and J. Wagner Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis Am J Physiol Renal Physiol, November 1, 2001; 281(5): F909 - F919. [Abstract] [Full Text] [PDF]

				I. LEHRKE, R. WALDHERR, E. RITZ, and J. WAGNER Renal Endothelin-1 and Endothelin Receptor Type B Expression in Glomerular Diseases with Proteinuria J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2321 - 2329. [Abstract] [Full Text] [PDF]

				K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1702 - 1711. [Abstract] [Full Text]

				J. WAGNER, F. GEHLEN, A. CIECHANOWICZ, and E. RITZ Angiotensin II Receptor Type 1 Gene Expression in Human Glomerulonephritis and Diabetes Mellitus J. Am. Soc. Nephrol., March 1, 1999; 10(3): 545 - 551. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673